title: Topic and systemic administration of natural alfa interferon in the treatment of female and male HPV genital infections.
abstract: The aim of the study was to evaluate the effectiveness and tolerance of topic and systemic administration of natural alfa-interferon from normal human leukocytes in the treatment of HPV lesions of the lower genital tract. From May 1991 through May 1992, 70 women (mean age = 29; range 16-42) and 51 men (mean age = 28; range 18-48) with histologically proven HPV genital lesions were studied. 43 patients and 32 male partners with subclinical infection underwent cream therapy (4 applications/day for 30 days) composed of natural alfa interferon and containing 1,000,000 IU/gr. 27 women and 19 men affected by florid infection underwent systemic i.m. therapy with natural alfa interferon in doses of 3,000,000 IU on alternate days for 30 days. The percentage of therapeutical success amounted to 55.8% for women and 78.1% for men subjected to topic therapy; for the 27 patients and 19 male partners treated with systemic therapy the final percentages of success were 70.3% respectively. Natural alfa interferon from normal human leucocytes seems to be a drug of good efficacy and tolerance in the treatment of HPV genital pathology.
authors.affiliation: II Department of Obstetrics and Gynecology, University of Rome La Sapienza, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Stentella
authors.forename: A
authors.initials: A
authors.lastname: Frega
authors.forename: F
authors.initials: F
authors.lastname: Di Renzi
authors.forename: P L
authors.initials: PL
authors.lastname: Palazzetti
authors.forename: A
authors.initials: A
authors.lastname: Pachì
mesh_terms: D000293:Adolescent; D000328:Adult; D003218:Condylomata Acuminata / Q000628:therapy; D005260:Female; D005831:Genital Diseases, Female / Q000628:therapy* / Q000821:virology; D005832:Genital Diseases, Male / Q000628:therapy* / Q000821:virology; D006801:Humans; D007273:Injections, Intramuscular; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000628:therapy*; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000628:therapy*
chemical_list: D016898:Interferon-alpha; D009824:Ointments